Waar het geregistreerd is
Elk register met het aantal geneesmiddelen en een paar ervan.
Canada
Health Canada · 8 geneesmiddelen
- Act-Hib10 MCG / 0.5 ML + 30 MCG / 0.5 ML · Kit, Powder For Solution · Sanofi Vaccines Canada LTD.
- Infanrix Hexa25 LF / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 10 LF / 0.5 ML + 40 MCG / 0.5 ML · Suspension · Glaxosmithkline INC
- Pentacel15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML · Suspension · Sanofi Vaccines Canada LTD.
- Liquid Pedvaxhib7.5 MCG / 0.5 ML + 125 MCG / 0.5 ML · Suspension · Merck Canada INC
Alle geneesmiddelen met Haemophilus influenzae type b-prp
Alle registers, per pagina. Sterktes en verpakkingen staan op de pagina van elk geneesmiddel.
10 resultaten
| Geneesmiddel | Register | Sterkte | Vorm | Status | Houder |
|---|---|---|---|---|---|
| Infanrix HexaCombinatie | Canada | 25 LF / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 10 LF / 0.5 ML + 40 MCG / 0.5 ML | Suspension | In de handel | Glaxosmithkline INC |
| Act-HibCombinatie | Canada | 10 MCG / 0.5 ML + 30 MCG / 0.5 ML | Kit, Powder For Solution | In de handel | Sanofi Vaccines Canada LTD. |
| PentacelCombinatie | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | In de handel | Sanofi Vaccines Canada LTD. |
| Prohibit Inj VaccineCombinatie | Canada | 23 MCG / 0.5 ML + 25 MCG / 0.5 ML | Liquid | Vervallen | Aventis Pasteur Limited |
| Pedvaxhib Inj PWSCombinatie | Canada | 15 MCG / VIAL + 250 MCG / VIAL | Powder For Solution | Vervallen | Merck Manufacturing Division, Division of Merck & Co., INC. |
| PediacelCombinatie | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | Vervallen | Sanofi Vaccines Canada LTD. |
| PentacelCombinatie | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Liquid, Powder For Solution | Vervallen | Sanofi Vaccines Canada LTD. |
| Liquid PedvaxhibCombinatie | Canada | 7.5 MCG / 0.5 ML + 125 MCG / 0.5 ML | Suspension | Vervallen | Merck Canada INC |
| Infanrix-Ipv/HibCombinatie | Canada | 30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML | Suspension | In de handel | Glaxosmithkline INC |
| Hiberix | Canada | 10 MCG / 0.5 ML | Powder For Solution | Vervallen | Glaxosmithkline INC |
In het kort
- Registers
- 1
- Geneesmiddelen
- 8
- Bedrijven
- 5